The audio file of today’s information session on the objectives, functioning and progress of the mRNA vaccine technology transfer hub in South Africa is available here: https://who.canto.global/b/PFPPA
- Dr Soumya Swaminathan, Chief Scientist, WHO
- Dr Martin Friede, Coordinator of the Initiative for Vaccine Research, WHO and the lead of the Long-Term Sustainable Manufacturing Workstream, COVAX Manufacturing Taskforce
- Charles Gore, Executive Director, Medicines Patent Pool
Additional information and resources:
- The mRNA vaccine technology transfer hub webpage
- FAQ on the mRNA vaccine technology hub
* * * * * * * * * *
What is the mRNA vaccine technology transfer hub?
The technology transfer hub, announced on 21 June 2021, aims to build capacity in low- and middle-income countries to produce mRNA vaccines through a centre of excellence and training (the mRNA vaccine technology hub). The hub is located at Afrigen, Cape Town, South Africa and will work with a network of technology recipients (spokes) in low- and middle-income countries.
WHO also logo